Dgx analyst ratings
WebThe 14 analysts offering 12-month price forecasts for Quest Diagnostics Inc have a median target of 148.50, with a high estimate of 166.00 and a low estimate of 140.00. The median estimate... WebApr 10, 2024 · Aquila Investment Management LLC purchased a new stake in Quest Diagnostics Incorporated (NYSE:DGX - Get Rating) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission.The institutional investor purchased 13,000 shares of the medical research company's stock, …
Dgx analyst ratings
Did you know?
WebApr 11, 2024 · NYSE:DGX Quest Diagnostics - DGX Competitors $142.88 +0.28 (+0.20%) (As of 04/6/2024 12:00 AM ET) Compare Today's Range $142.16 $143.78 50-Day Range $131.53 $148.64 52-Week Range $120.40 $158.34 Volume 886,206 shs Average Volume 1.22 million shs Market Capitalization $15.91 billion P/E Ratio 18.04 Dividend Yield … WebFeb 2, 2024 · I n recent trading, shares of Quest Diagnostics, Inc. (Symbol: DGX) have crossed above the average analyst 12-month target price of $132.69, changing hands for $133.34/share. When a stock...
WebApr 6, 2024 · Seeking Alpha's authors provide a stock rating for Quest Diagnostics Incorporated (DGX). Ratings range from 'Very Bullish' to 'Very Bearish'. WebApr 6, 2024 · Quest Diagnostics stock has received a consensus rating of hold. The average rating score is and is based on 7 buy ratings, 22 hold ratings, and 1 sell ratings. What was the 52-week low...
WebApr 10, 2024 · Analysts Offer Insights on Healthcare Companies: Lifecore Biomedical (LFCR), Prestige Consumer Healthcare (PBH) and Quest Diagnostics (DGX) Mar. 17, 2024 at 12:40 p.m. ET on TipRanks.com WebBased on analysts offering 12 month price targets for DGX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .
WebView the real-time DGX price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper statement fees may apply. ... Quest Diagnostics DGX has observed the following analyst ratings within the last quarter: Bullish Somewhat ...
WebBarchart provides Analyst Ratings to give you another tool to gauge the possible future performance of a stock. Analyst Ratings are available for US and Canadian equities. … lithophane thickness settingsWebApr 14, 2024 · Quest Diagnostics (NYSE:DGX – Get Rating) last posted its quarterly earnings results on Thursday, February 2nd.The medical research company reported $1.98 EPS for the quarter, topping the ... lithophane tealight holdersWebAnalyst Rating / Earnings Estimates. Current Rating See More. Hold. Based on 11 analysts offering recommendations. Earnings Estimates - Current Qtr 03/31/23 See More. ... (DGX) are available to recipients and living donors across the United States (excluding Alaska and Hawaii), broadening access for both donor and patient. ... lithophane testWebMar 17, 2024 · Analyst Expectations for Quest Diagnostics's Future - Quest Diagnostics (NYSE:DGX) - Benzinga 390.28 1.47% 304.65 0.7% 26431.37 6.8301% 318.72 1.4% 182.12 1.99% TLT 106.97 1.61% Analyst... lithophane testerWebApr 6, 2024 · SECAUCUS, N.J., March 20, 2024 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), the nation’s leading provider of diagnostic information... 20d ago. DGX. … lithophane tea setWebApr 10, 2024 · According to 22 stock analysts, the average 12-month stock price forecast for DGX stock is $153.54, which predicts an increase of 7.09%. The lowest target is … lithophane test printWebFind the latest Quest Diagnostics Incorporated DGX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. ... Date Range. investment rating ... lithophane tool